Creative Medical Technology Holdings, Inc. Amortization of Debt Discount (Premium)
Creative Medical Technology Holdings, Inc. (CELZ) reported Amortization of Debt Discount (Premium) of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2023-03-31
- Creative Medical Technology Holdings, Inc. amortization of debt discount (premium) for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- Creative Medical Technology Holdings, Inc. amortization of debt discount (premium) for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- Creative Medical Technology Holdings, Inc. amortization of debt discount (premium) for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- Creative Medical Technology Holdings, Inc. amortization of debt discount (premium) for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- Creative Medical Technology Holdings, Inc. amortization of debt discount (premium) for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Creative Medical Technology Holdings, Inc. amortization of debt discount (premium) for fiscal 2021 was $4.16M, a 324.29% increase from fiscal 2020.
- Creative Medical Technology Holdings, Inc. amortization of debt discount (premium) for fiscal 2020 was $979.96K, a 43.14% decline from fiscal 2019.
- Creative Medical Technology Holdings, Inc. amortization of debt discount (premium) for fiscal 2019 was $1.72M, a 36.95% increase from fiscal 2018.
| Period end | Amortization of Debt Discount (Premium) 0 month | Amortization of Debt Discount (Premium) 1 month | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $0.00 10-K · filed 2023-03-31 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | $2.40M derived: sum of 4 quarters · filed 2023-03-31 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | $2.40M derived: sum of 3 quarters · filed 2023-03-31 | $3.71M derived: sum of 4 quarters · filed 2023-03-31 | ||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 | $2.40M derived: sum of 2 quarters · filed 2023-03-31 | $3.71M derived: sum of 3 quarters · filed 2023-03-31 | $3.93M derived: sum of 4 quarters · filed 2023-03-31 | ||
| 2021-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $3.71M derived: sum of 2 quarters · filed 2023-03-31 | $3.93M derived: sum of 3 quarters · filed 2023-03-31 | $4.16M 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.52M derived: sum of 2 quarters · filed 2022-11-10 | $1.76M 10-Q · filed 2022-11-10 | $1.93M derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | $220.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $451.61K 10-Q · filed 2022-08-12 | $626.68K derived: sum of 3 quarters · filed 2022-08-12 | $887.66K derived: sum of 4 quarters · filed 2022-08-12 | ||
| 2021-03-31 | $231.23K 10-Q · filed 2022-05-13 | $406.29K derived: sum of 2 quarters · filed 2022-05-13 | $667.28K derived: sum of 3 quarters · filed 2022-05-13 | $921.37K derived: sum of 4 quarters · filed 2022-05-13 | ||
| 2020-12-31 | $175.06K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $436.04K derived: sum of 2 quarters · filed 2022-03-30 | $690.13K derived: sum of 3 quarters · filed 2022-03-30 | $979.96K 10-K · filed 2022-03-30 | ||
| 2020-09-30 | $260.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $515.07K derived: sum of 2 quarters · filed 2021-11-15 | $804.90K 10-Q · filed 2021-11-15 | $1.18M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $254.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $543.92K 10-Q · filed 2021-08-16 | $916.38K derived: sum of 3 quarters · filed 2021-08-16 | $1.41M derived: sum of 4 quarters · filed 2021-08-16 | ||
| 2020-03-31 | $289.82K 10-Q · filed 2021-05-17 | $662.29K derived: sum of 2 quarters · filed 2021-05-17 | $1.15M derived: sum of 3 quarters · filed 2021-05-17 | $1.62M derived: sum of 4 quarters · filed 2021-05-17 | ||
| 2019-12-31 | $372.47K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $861.17K derived: sum of 2 quarters · filed 2021-03-17 | $1.33M derived: sum of 3 quarters · filed 2021-03-17 | $1.72M 10-K · filed 2021-03-17 | ||
| 2019-09-30 | $488.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $954.74K derived: sum of 2 quarters · filed 2020-11-13 | $1.35M 10-Q · filed 2020-11-13 | $1.73M derived: sum of 4 quarters · filed 2020-11-13 | ||
| 2019-06-30 | $466.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $862.28K 10-Q · filed 2020-08-14 | $1.24M derived: sum of 3 quarters · filed 2020-08-14 | $1.57M derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2019-03-31 | $396.24K 10-Q · filed 2020-05-15 | $776.33K derived: sum of 2 quarters · filed 2020-05-15 | $1.11M derived: sum of 3 quarters · filed 2020-05-15 | $1.50M derived: sum of 4 quarters · filed 2020-05-15 | ||
| 2018-12-31 | $380.09K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-06 | $708.94K derived: sum of 2 quarters · filed 2020-04-06 | $1.10M derived: sum of 3 quarters · filed 2020-04-06 | $1.26M 10-K · filed 2020-04-06 | ||
| 2018-09-30 | $0.00 10-Q · filed 2018-11-14 | $328.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $721.01K derived: sum of 2 quarters · filed 2019-11-14 | $878.35K 10-Q · filed 2019-11-14 | $1.03M derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | $392.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $549.50K 10-Q · filed 2019-08-13 | $698.47K derived: sum of 3 quarters · filed 2019-08-13 | $816.11K derived: sum of 4 quarters · filed 2019-08-13 | ||
| 2018-04-11 | $10.00K 10-K · filed 2019-04-01 | |||||
| 2018-03-31 | $157.34K 10-Q · filed 2019-05-20 | $306.32K derived: sum of 2 quarters · filed 2019-05-20 | $423.95K derived: sum of 3 quarters · filed 2019-05-20 | $479.89K derived: sum of 4 quarters · filed 2019-05-20 | ||
| 2018-01-17 | $4.00K 10-Q · filed 2018-08-14 | |||||
| 2017-12-31 | $148.98K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $266.61K derived: sum of 2 quarters · filed 2019-04-01 | $322.56K derived: sum of 3 quarters · filed 2019-04-01 | $322.56K 10-K · filed 2019-04-01 | ||
| 2017-10-23 | $25.00K 10-K · filed 2019-04-01 | |||||
| 2017-09-30 | $117.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $173.58K derived: sum of 2 quarters · filed 2018-11-14 | $173.58K 10-Q · filed 2018-11-14 | $173.58K derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2017-06-30 | $55.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $55.94K 10-Q · filed 2018-08-14 | $55.94K derived: sum of 3 quarters · filed 2018-08-14 | $55.94K derived: sum of 4 quarters · filed 2018-08-14 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-08-03 | $0.00 derived: sum of 2 quarters · filed 2018-08-03 | $0.00 derived: sum of 3 quarters · filed 2018-08-03 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $0.00 derived: sum of 2 quarters · filed 2018-03-29 | $0.00 10-K · filed 2018-03-29 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $0.00 10-Q · filed 2017-11-13 | ||||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |